• Je něco špatně v tomto záznamu ?

Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study

I. Baert, J. Freeman, T. Smedal, U. Dalgas, A. Romberg, A. Kalron, H. Conyers, I. Elorriaga, B. Gebara, J. Gumse, A. Heric, E. Jensen, K. Jones, K. Knuts, B. Maertens de Noordhout, A. Martic, B. Normann, BO. Eijnde, K. Rasova, C. Santoyo Medina,...

. 2014 ; 28 (7) : 621-31.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014520

BACKGROUND: Evaluation of treatment effects on walking requires appropriate and responsive outcome measures. OBJECTIVES: To determine responsiveness of 5 walking measures and provide reference values for clinically meaningful improvements, according to disability level, in persons with multiple sclerosis (pwMS). METHODS: Walking tests were measured pre- and postrehabilitation in 290 pwMS from 17 European centers. Combined anchor- and distribution-based methods determined responsiveness of objective short and long walking capacity tests (Timed 25-Foot Walk [T25FW] and 2- and 6-Minute Walk Tests [2MWT and 6MWT] and of the patient-reported Multiple Sclerosis Walking Scale-12 [MSWS-12]). A global rating of change scale, from patients' and therapists' perspective, was used as external criteria to determine the area under the receiver operating characteristic curve (AUC), minimally important change (MIC), and smallest real change (SRC). Patients were stratified into disability subgroups (Expanded Disability Status Scale score ≤4 [n = 98], >4 [n = 186]). RESULTS: MSWS-12, 2MWT, and 6MWT were more responsive (AUC 0.64-0.73) than T25FW (0.50-0.63), especially in moderate to severely disabled pwMS. Clinically meaningful changes (MICs) from patient and therapist perspective were -10.4 and -11.4 for MSWS-12 (P < .01), 9.6 m and 6.8 m for 2MWT (P < .05), and 21.6 m (P < .05) and 9.1 m (P = .3) for 6MWT. In subgroups, MIC was significant from patient perspective for 2MWT (10.8 m) and from therapist perspective for MSWS-12 (-10.7) in mildly disabled pwMS. In moderate to severely disabled pwMS, MIC was significant for MSWS-12 (-14.1 and -11.9). CONCLUSIONS: Long walking tests and patient-reported MSWS-12 were more appropriate than short walking tests in detecting clinically meaningful improvement after physical rehabilitation, particularly the MSWS-12 for moderate to severely disabled pwMS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014520
003      
CZ-PrNML
005      
20150428120719.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1545968314521010 $2 doi
035    __
$a (PubMed)24503204
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Baert, Ilse $u Hasselt University, Diepenbeek, Belgium ilse.baert@uhasselt.be.
245    10
$a Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study / $c I. Baert, J. Freeman, T. Smedal, U. Dalgas, A. Romberg, A. Kalron, H. Conyers, I. Elorriaga, B. Gebara, J. Gumse, A. Heric, E. Jensen, K. Jones, K. Knuts, B. Maertens de Noordhout, A. Martic, B. Normann, BO. Eijnde, K. Rasova, C. Santoyo Medina, V. Truyens, I. Wens, P. Feys,
520    9_
$a BACKGROUND: Evaluation of treatment effects on walking requires appropriate and responsive outcome measures. OBJECTIVES: To determine responsiveness of 5 walking measures and provide reference values for clinically meaningful improvements, according to disability level, in persons with multiple sclerosis (pwMS). METHODS: Walking tests were measured pre- and postrehabilitation in 290 pwMS from 17 European centers. Combined anchor- and distribution-based methods determined responsiveness of objective short and long walking capacity tests (Timed 25-Foot Walk [T25FW] and 2- and 6-Minute Walk Tests [2MWT and 6MWT] and of the patient-reported Multiple Sclerosis Walking Scale-12 [MSWS-12]). A global rating of change scale, from patients' and therapists' perspective, was used as external criteria to determine the area under the receiver operating characteristic curve (AUC), minimally important change (MIC), and smallest real change (SRC). Patients were stratified into disability subgroups (Expanded Disability Status Scale score ≤4 [n = 98], >4 [n = 186]). RESULTS: MSWS-12, 2MWT, and 6MWT were more responsive (AUC 0.64-0.73) than T25FW (0.50-0.63), especially in moderate to severely disabled pwMS. Clinically meaningful changes (MICs) from patient and therapist perspective were -10.4 and -11.4 for MSWS-12 (P < .01), 9.6 m and 6.8 m for 2MWT (P < .05), and 21.6 m (P < .05) and 9.1 m (P = .3) for 6MWT. In subgroups, MIC was significant from patient perspective for 2MWT (10.8 m) and from therapist perspective for MSWS-12 (-10.7) in mildly disabled pwMS. In moderate to severely disabled pwMS, MIC was significant for MSWS-12 (-14.1 and -11.9). CONCLUSIONS: Long walking tests and patient-reported MSWS-12 were more appropriate than short walking tests in detecting clinically meaningful improvement after physical rehabilitation, particularly the MSWS-12 for moderate to severely disabled pwMS.
650    _2
$a dospělí $7 D000328
650    12
$a posuzování pracovní neschopnosti $7 D004185
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a roztroušená skleróza $x diagnóza $x rehabilitace $7 D009103
650    12
$a techniky fyzikální terapie $x normy $7 D026741
650    _2
$a obnova funkce $7 D020127
650    _2
$a referenční standardy $7 D012015
650    _2
$a výsledek terapie $7 D016896
650    _2
$a chůze $x fyziologie $7 D016138
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Freeman, Jennifer $u Plymouth University, Plymouth, UK.
700    1_
$a Smedal, Tori $u Haukeland University Hospital, Bergen, Norway.
700    1_
$a Dalgas, Ulrik $u Aarhus University, Aarhus, Denmark.
700    1_
$a Romberg, Anders $u Masku Neurological Rehabilitation Center, Masku, Finland.
700    1_
$a Kalron, Alon $u Sheba Medical Center, Tel-Hashomer, Israel.
700    1_
$a Conyers, Helen $u Poole Hospital, NHS Foundation Trust, Dorset, UK.
700    1_
$a Elorriaga, Iratxe $u Eugenia Epalza Rehabilitation Center, Bilbao, Spain.
700    1_
$a Gebara, Benoit $u National Multiple Sclerosis Center, Melsbroek, Belgium.
700    1_
$a Gumse, Johanna $u Helsinki MS-Neuvola, Helsinki, Finland.
700    1_
$a Heric, Adnan $u Multiple Sclerosis Center, Hakadal AS, Norway.
700    1_
$a Jensen, Ellen $u Multiple Sclerosis Hospital, Haslev, Denmark Multiple Sclerosis Hospital, Ry, Denmark.
700    1_
$a Jones, Kari $u Haukeland University Hospital, Bergen, Norway.
700    1_
$a Knuts, Kathy $u Rehabilitation and Multiple Sclerosis Center, Overpelt, Belgium.
700    1_
$a Maertens de Noordhout, Benoît $u Centre Neurologique et de Réadaptation Fonctionelle, Fraiture-en-Condroz, Belgium.
700    1_
$a Martic, Andrej $u University Medical Center, Ljubljana, Slovenia.
700    1_
$a Normann, Britt $u Kongsgaarden Physiotherapy AS/Nordland Hospital Trust, Bodø, Norway.
700    1_
$a Eijnde, Bert O $u Hasselt University, Diepenbeek, Belgium.
700    1_
$a Rasova, Kamila $u Charles University, Prague, Czech Republic.
700    1_
$a Santoyo Medina, Carmen $u Hospital de Dia de Barcelona, CEMCat, Barcelona, Spain.
700    1_
$a Truyens, Veronik $u Rehabilitation and Multiple Sclerosis Center, Overpelt, Belgium.
700    1_
$a Wens, Inez $u Hasselt University, Diepenbeek, Belgium.
700    1_
$a Feys, Peter $u Hasselt University, Diepenbeek, Belgium.
773    0_
$w MED00180455 $t Neurorehabilitation and neural repair $x 1552-6844 $g Roč. 28, č. 7 (2014), s. 621-31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24503204 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150428121022 $b ABA008
999    __
$a ok $b bmc $g 1072101 $s 897398
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 28 $c 7 $d 621-31 $i 1552-6844 $m Neurorehabilitation and neural repair $n Neurorehabil Neural Repair $x MED00180455
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace